Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

Israel’s SimilarWeb Raises $15 Million in New Funding


SimilarWeb-high-res

Israeli digital insight and website traffic analysis company SimilarWeb announced that it has raised $15 million dollars from Naspers and Lord David Alliance in a Series D round of investment. The new funds will be used to expand the company’s services.

SimilarWeb states that it providing mobile insights is a crucial aspect of its strategy, with apps at the center of this mobile universe. This investment will enable it to make headway in the mobile sphere and give marketing professionals the insights to navigate our digital world.

In September, SimilarWeb launched the first part of its mobile analysis features which focus on acquisition and app store optimization insights. These features help marketers boost visibility and attract new users. But the company says that, “we still weren’t seeing the whole picture – we still lacked the ability to understand what was happening inside the apps themselves. We’ve been working on this challenge for quite some time, and in the coming weeks we’ll be ready to release our highly-anticipated next phase of our mobile measurement, mobile app engagement onto SimilarWeb Pro.”

Or Offer founded SimilarWeb with Nir Cohen on March 3, 2009 in Tel-Aviv. Its clients included clients include PayPal, eBay Inc., Flipkart and Adidas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement
cialis cialis satış